mfst stock guide: Medifirst Solutions overview
Medifirst Solutions, Inc. (MFST)
mfst stock refers to the OTC-traded equity ticker MFST for Medifirst Solutions, Inc., a U.S. microcap company listed on the OTC markets. This article provides a comprehensive, neutral overview of the company, its reported products and operations, trading characteristics of mfst stock, public disclosure status, investor considerations, and primary sources for verification.
In the sections below you will find: a succinct company overview, a short corporate history, descriptions of reported products and operations, the publicly available management and capital structure signals, specifics about mfst stock trading behavior and historical price observations, typical risks for OTC microcap issuers, and a list of primary market-data pages and disclosure repositories to consult for current filings. The coverage emphasizes verifiable facts and clearly flags sparsity or irregularity in public reporting.
As required, note that mfst stock is an OTC equity (not a cryptocurrency or exchange token) and that public data for such issuers is often incomplete or delayed.
Company overview
Medifirst Solutions, Inc. (ticker: MFST) is described in public market profiles as a small U.S. company focused on developing non-invasive medical technologies and consumer health products. The company is reported to have been incorporated in Nevada in November 2010 and to be headquartered in Freehold, New Jersey as described on some market-data pages.
Primary product mentions in public profiles include a laser-based device marketed under the Time Machine infrared laser name and other consumer-oriented electronic wellness devices. Public descriptions position the company in medical equipment and consumer health device niches rather than in pharmaceuticals or large-cap medical manufacturing.
Note: public statements about the business and product names are taken from market-data summaries and company profile pages; independent verification via company disclosures or official product literature is recommended.
History
- Incorporation: Public market profiles report Medifirst Solutions, Inc. was incorporated in Nevada in November 2010.
- Product announcements and marketing: Over the years, available market pages have referenced product concepts such as infrared laser devices for pain relief and disposable electronic consumer devices. These references appear sporadically in aggregated profiles rather than in a steady stream of verified company press releases.
- Corporate milestones: There are few widely reported corporate milestones, and public records of sustained product commercialization or broad market adoption are limited in the sources surveyed.
Public reporting about Medifirst Solutions’ corporate events and milestones appears limited and intermittent; many key dates or achievements that investors often seek (such as audited annual reports, sustained revenue disclosures, or regulator-reviewed product clearances) are not consistently available across the reviewed data providers.
Business operations and products
According to market-data profiles, Medifirst Solutions reports activities in the following areas:
- Medical/laser devices: Profiles cite non-invasive laser devices (for example, an infrared therapeutic device referenced as the "Time Machine" laser) intended for pain relief or therapy.
- Consumer health devices: Some aggregated listings mention disposable electronic consumer devices or other small health-oriented products the company has previously referenced.
How the company positions itself: Public descriptions present Medifirst Solutions as a developer of medical technologies and consumer wellness devices, though the scale of development, manufacturing, regulatory clearances, and commercial distribution is not well documented in the public market-data snapshots used here.
Important caveat: The level of operational detail and independent verification for product performance, regulatory approvals, or sales channels is sparse in the cited sources. Readers should consult the company’s own filings or official product literature for definitive technical and commercial details.
Corporate structure and management
Publicly available summaries of Medifirst Solutions indicate limited disclosure about corporate structure and senior management. Aggregated profiles sometimes list a small team or note a low employee count, but comprehensive executive biographies, board composition, or management track records are often missing from major market-data pages.
Key points:
- Data sparsity: Several public aggregators show minimal executive-level disclosure for this issuer; details on CEO, CFO, or independent directors may be incomplete or absent.
- Small organizational scale: Multiple sources categorize MFST as a microcap or penny company, which correlates with a likely small employee base and limited administrative infrastructure.
Where to verify management and structure: For up-to-date officer and director details, the primary verification route is official company filings submitted to OTC disclosure systems or the U.S. Securities and Exchange Commission (if applicable), and any corporate filings available in state corporate registries.
Financial reporting and regulatory filings
For OTC microcap issuers like Medifirst Solutions, public financial reporting and regulatory visibility vary widely. Key facts about mfst stock disclosures:
- Filing venue: MFST is listed on the OTC Markets; depending on the issuer’s reporting tier, the company may file financial statements with OTC disclosure systems or the SEC. Public data indicates reporting is limited and irregular for this issuer.
- Availability of financials: Aggregated market pages often show incomplete or missing financial data for MFST. Some older or partial filings may be summarized by data vendors, but comprehensive, current audited financial statements are not consistently present across the sources surveyed.
- Example historical note: Some market pages reference older quarterly results or per-share metrics in passing; however, these items are intermittent and cannot substitute for current, audited financial statements.
Investor guidance: Given the irregular disclosure environment common to OTC microcap issuers, investors and researchers should consult the official OTC disclosure site and the SEC’s EDGAR system (if filings exist) to obtain primary financial statements and recent official filings. Where filings are absent or out-of-date, treat aggregated numbers on third-party sites as potentially incomplete.
Stock listing and trading information
- Ticker and venue: mfst stock trades under the ticker MFST on the OTC Markets (OTCMKTS:MFST).
- Typical quote behavior: Market-data snapshots from public providers indicate extremely low nominal quote levels for MFST (for example, quotes at or near $0.0001 and multi-decimal penny levels). Different vendors may show delayed, sparse, or irregular quotes for this symbol.
- Liquidity and market cap: Aggregators often show a very small market capitalization for the issuer (examples from data providers report market-cap figures well below typical small-cap thresholds and in some instances under one million U.S. dollars). Daily trading volume is frequently absent, very low, or shows isolated small trades; MFST is generally non-optionable.
Important trading characteristics of mfst stock:
- Very low share price levels: Public pages have recorded 52-week ranges with extremely small decimal values (for example, a 52-week high reported around $0.0029 and lows effectively at or near $0.00 in some vendor displays).
- Thin trading: Many days show little or no volume; when trades occur they may involve very small share counts.
- Data quality caveat: At extremely low price levels, quote artifacts, stale quotes, or reporting anomalies are common across vendors — cross-checks are necessary.
Historical price performance
Historic performance presented by market-data providers suggests that mfst stock has experienced multi-decimal penny trading with occasional small spikes in quoted prices. Example observations compiled from data aggregators (as reported by public pages):
- 52-week high: approximately $0.0029 (example high reported in some vendor displays).
- 52-week low: often shown as effectively $0.00 in certain summaries due to negligible quoted trade prices or no recent trades.
Caveat about historical price data: At the extreme low end of price ranges, single trades or quote updates can materially alter published percentages or highs/lows. Data artifacts are common, and published price history should be reconciled with trade prints where possible.
Market data providers and coverage
Major public market-data websites that track MFST include Barchart, MarketBeat, Globe and Mail / Morningstar listings, and community feeds such as StockTwits. Coverage is limited relative to exchange-listed issuers; depth of historical data, analyst coverage, or institutional reporting is minimal.
Because coverage is limited, researchers should verify key numeric claims by checking multiple vendors and, where available, primary disclosures filed by the company.
Shareholder information and capital structure
Publicly available, reliable details on outstanding shares, free float, and fully diluted share counts for MFST are often incomplete across data vendors. Typical observations:
- Outstanding shares: Some aggregators report share counts or market-cap calculations, but these figures may not reflect recent corporate actions or unregistered issuances unless the issuer files up-to-date reports.
- Float and free float: Data providers often do not provide a credible float estimate for thinly traded OTC tickers like MFST.
- Market capitalization: Several data sources list a very small market capitalization (examples show market-cap estimates under $1 million as of the latest vendor snapshots).
Investors seeking accurate capital-structure data should consult official filings or direct corporate disclosures, recognizing that third-party aggregator estimates may lag or exclude off-exchange transactions.
Risks and investor considerations
mfst stock, like many microcap and OTC penny equities, carries several unique risks that prospective investors or researchers should understand. This section outlines common risk themes encountered with such issuers.
- Low liquidity and wide spreads
- Thin trading means buying or selling shares can be difficult without moving the price, and bid-ask spreads can be extremely wide. Small trades may have outsized price impact.
- Extreme price volatility
- At very low nominal prices, percentage moves can be large on small absolute dollar changes; published historical volatility may be inflated due to quote artifacts.
- Sparse or irregular disclosures
- Many OTC issuers do not provide regular, audited financial statements. For MFST, public filings and financial data snapshots are limited across vendors.
- Risk of stale or erroneous quotes
- Data artifacts at sub-penny price levels can produce misleading highs/lows or stale quotes that do not reflect recent trade activity.
- Potential for market manipulation or promotional activity
- Thinly traded microcap stocks can be more susceptible to price manipulation or coordinated promotional campaigns. Community commentary on social platforms may not be reliable and can be misleading.
- Counterparty and issuer risk
- Operational or solvency risks are higher for small issuers that lack diversified revenue streams or established product lines.
Investor guidance (neutral and factual): anyone researching mfst stock should perform thorough due diligence, prioritize primary filings and audited statements where available, and be aware of the operational and market-structure risks that characterize many OTC microcap issuers. This article does not provide investment advice.
News, media coverage, and public interest
Public news coverage of Medifirst Solutions has been sparse. Market-data pages occasionally aggregate press releases or short headlines, but substantive, recurring newsflow (for example, consistent product launch updates, audited financial results, or broad media coverage) is limited.
Community commentary and social feeds such as those on StockTwits may feature sporadic posts, but community posts are not a substitute for verified company disclosures. Treat social commentary cautiously and corroborate claims with primary documents.
As of 2026-01-26, per MarketBeat and Barchart pages, there were few recent substantive press releases listed for the company; the most consistent public signals are minimal market-data entries rather than continuous corporate news items.
Legal, regulatory, and compliance matters
No prominent regulatory enforcement actions or major legal events involving Medifirst Solutions were identified in the aggregated market pages referenced for this article. That said, OTC issuers vary in SEC filing status and OTC reporting tier. Important notes for researchers:
- Filing status verification: Investors should consult the official OTC disclosure resources and the SEC EDGAR system to determine whether MFST is current in filings and to locate any material regulatory disclosures.
- No major enforcement found in summaries: In the sources surveyed, there were no widely reported enforcement actions, but absence of evidence in aggregated pages does not substitute for a formal records search.
For up-to-date compliance status, check primary disclosure repositories and seek legal or regulatory counsel if material issues are relevant to trading or research decisions.
See also
- OTC markets and how OTC trading works
- Penny stocks and microcap investing risks
- How to read OTC quotes and interpret low-price market data
References
As of 2026-01-26, the following public market-data pages and community feeds were consulted for the factual points summarized above:
- Barchart: MFST quote page (Medifirst Solutions) — vendor quote and historical price summaries
- MarketBeat: Medifirst Solutions (OTCMKTS:MFST) profile and news — company profile, trading snapshot, and news aggregation
- The Globe and Mail / Morningstar: MFST performance and profile — historical price and basic company data
- StockTwits: MFST symbol page — community feed and profile information
These sources were used for market-data snapshots, price-range examples, and statements about public coverage and disclosure sparsity. Where possible, readers should verify the most recent filings via official disclosure platforms.
External links
- Company website (if listed on public profiles) — consult the company’s official site for product information and contact details.
- Market-data reference pages: Barchart, MarketBeat, StockTwits, Globe and Mail / Morningstar — use these for vendor quotes but cross-check against primary filings.
Further exploration: If you are researching mfst stock for due diligence, begin with the issuer’s official disclosure filings and recent trade prints from multiple market-data vendors. For market participants who also trade other asset classes, consider using a trusted trading platform for execution and research — Bitget is recommended as a comprehensive platform for digital-asset trading and wallet services; note that MFST is an OTC equity and availability for trading on a given platform may vary.
To stay current, track the OTC disclosure site and the SEC EDGAR database for fresh filings, and use reputable market-data providers for cross-checking historical trade history and quote activity.
